首页> 外文OA文献 >Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

【2h】

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

机译：心率，血压和β受体阻滞剂剂量对慢性心力衰竭患者结局的影响以及卡维地洛和酒石酸美托洛尔之间结局的差异：COMET试验结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Metra, Marco; Torp-Pedersen, Christian; Swedberg, Karl; Cleland, John G.F.; Di Lenarda, Andrea; Komajda, Michel; Remme, Willem J.; Lutiger, Beatrix; Scherhag, Armin; Lukas, Mary Ann; Charlesworth, Andrew; Poole-Wilson, Philip A.;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. [J] . Poole-Wilson PA, Swedberg K, Cleland JG, The Lancet . 2003,第9377期

机译：卡维地洛或美托洛尔欧洲试验（COMET）中卡维地洛和美托洛尔对慢性心力衰竭患者临床结局的比较：随机对照试验。
2. Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial. [J] . Olsson LG, Swedberg K, Cleland JG, European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology . 2007,第8期

机译：血浆NT-pro BNP在接受β受体阻滞剂治疗的患者的慢性心力衰竭中的预后重要性：卡维地洛或美托洛尔欧洲试验（COMET）试验的结果。
3. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: Is there an influence of beta-blocker dose?: Findings from the SHIFT (Systolic Heart failure treatment with the I f inhibitor ivabradine Trial) study [J] . SwedbergK., KomajdaM., B?hmM., Journal of the American College of Cardiology . 2012,第22期

机译：依伐布雷定对充血性心力衰竭患者心率降低结局的影响：β-受体阻滞剂剂量是否有影响？：SHIFT（使用If抑制剂依伐布雷定试验进行收缩性心力衰竭治疗）的研究结果
4. Clinical characteristics, management, and outcomes of patients with high risk chronic heart failure referred to a heart failure clinic in Saudi Arabia [C] . Waleed M.A. World Congress on Heart Disease. . 2013

机译：高危慢性心力衰竭患者的临床特征，管理和结果提及沙特阿拉伯的心力衰竭诊所
5. Examining the Effect of Heart Rate and Blood Pressure on 30-Day Admission Rates in Heart Failure Patients [D] . Massey, Caitlin A. 2019

机译：检查心力衰竭患者30天入院率的心率和血压的影响
6. Effects of metoprolol and carvedilol on pre‐existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET) [O] . Christian Torp‐Pedersen, Marco Metra, Andrew Charlesworth, 2007

机译：美托洛尔和卡维地洛对慢性心力衰竭患者先前和新发糖尿病的影响：来自卡维地洛或美托洛尔欧洲试验（COMET）的数据
7. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. [O] . Metra M, Torp-Pedersen C, Swedberg K, 2005

机译：心率，血压和β受体阻滞剂剂量对慢性心力衰竭患者结局以及卡维地洛和酒石酸美托洛尔之间结局差异的影响：COMET试验结果。

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

著录项

相似文献

相关主题

期刊订阅